Amoéba
Develops natural microbiological solutions to manage bacterial and fungal risks.
ALMIB | PA
Overview
Corporate Details
- ISIN(s):
- FR0011051598 (+2 more)
- LEI:
- 9695005QNE7C8Z0LXU64
- Country:
- France
- Address:
- 38 AVENUE DES FRERES MONTGOLFIER, 69680 CHASSIEU
- Website:
- https://amoeba-nature.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of other chemical products
Description
Amoéba is a biotechnology company that develops natural microbiological solutions for managing bacterial and fungal risks. The company's core technology is based on the patented use of the amoeba *Willaertia magna* C2c Maky and its biocidal properties. Its primary focus is on agricultural biocontrol, offering a biofungicide derived from a mechanically lysed amoeba. This product targets plant diseases such as mildews, rusts, and powdery mildew, providing a biological alternative to chemical treatments. Amoéba has also developed applications for its technology in the treatment of bacterial risk in industrial water systems, on surfaces, and for chronic wounds.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-10-03 17:45 |
Amoéba : un premier semestre 2024 confirmant le pivot stratégique vers une entr…
|
French | 384.8 KB | ||
| 2024-10-02 17:45 |
Cessation du contrat de liquidité
|
French | 342.2 KB | ||
| 2024-10-02 17:45 |
Déclaration du nombre total de droits de vote et du nombre d'actions composant …
|
French | 231.3 KB | ||
| 2024-08-28 17:45 |
AMOEBA prepares for the commercial launch of the AXPERA Product Line in the USA…
|
English | 348.5 KB | ||
| 2024-08-28 17:45 |
AMOEBA prépare le lancement commercial de la gamme AXPERA aux États-Unis grâce …
|
French | 362.5 KB | ||
| 2024-07-05 17:45 |
AMOEBA: Déclaration du nombre total de droits de vote et du nombre d’actions co…
|
French | 240.2 KB | ||
| 2024-07-05 17:45 |
AMOEBA: Bilan semestriel du contrat de liquidité
|
French | 453.1 KB | ||
| 2024-07-02 08:30 |
AMOÉBA : NOUVELLE STRUCTURE JURIDIQUE POUR OPTIMISER LES ACTIVITES COMMERCIALES
|
French | 381.7 KB | ||
| 2024-07-02 08:30 |
AMOEBA: A NEW LEGAL STRUCTURE TO MAXIMISE COMMERCIAL ACTIVITIES
|
English | 367.0 KB | ||
| 2024-06-10 17:45 |
CONFIRMATION DU POTENTIEL DE LA COSMÉTIQUE DANS LE DÉVELOPPEMENT D’AMOÉBA
|
French | 359.6 KB | ||
| 2024-06-10 17:45 |
CONFIRMATION OF THE DEVELOPMENT POTENTIAL OF AMOEBA IN COSMETICS
|
English | 356.2 KB | ||
| 2024-05-23 18:00 |
AMOEBA: ASSEMBLEE GENERALE ORDINAIRE ET EXTRAORDINAIRE DU 27 JUIN 2024 - Modali…
|
French | 339.1 KB | ||
| 2024-05-23 18:00 |
AMOEBA: ORDINARY AND EXTRAORDINARY GENERAL MEETING OF 27 JUNE 2024 - Availabili…
|
English | 331.9 KB | ||
| 2024-05-06 17:45 |
AMOEBA : Déclaration du nombre total de droits de vote et du nombre d’actions c…
|
French | 240.4 KB | ||
| 2024-05-02 18:00 |
Le Conseil d’administration d’Amoéba renouvelé, pour soutenir les nouvelles amb…
|
French | 367.6 KB |
Automate Your Workflow. Get a real-time feed of all Amoéba filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Amoéba
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Amoéba via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-08-30 | N/A | Other | Buy | 6,300 | 3,609.90 EUR |
| 2024-08-29 | N/A | Other | Sell | 5,500 | 3,564.00 EUR |
| 2024-08-28 | N/A | Other | Buy | 3,200 | 1,782.08 EUR |
| 2024-08-27 | N/A | Other | Buy | 20,049 | 11,231.45 EUR |
| 2024-08-26 | N/A | Other | Buy | 31,107 | 17,441.69 EUR |
| 2024-08-22 | N/A | Other | Buy | 2,255 | 1,298.88 EUR |
| 2024-08-20 | N/A | Other | Buy | 16,664 | 8,838.59 EUR |
| 2024-08-19 | N/A | Other | Buy | 13,390 | 6,795.43 EUR |
| 2024-08-16 | N/A | Other | Buy | 6,745 | 3,468.28 EUR |
| 2024-08-09 | N/A | Other | Buy | 40,748 | 21,559.77 EUR |
Peer Companies
